DLBCL, Diffused Large B Cell Lymphoma: Clinical Trials

1 trial for DLBCL, Diffused Large B Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow DLBCL, Diffused Large B Cell Lymphoma: new trials by email Literature Review of DLBCL, Diffused Large B Cell Lymphoma trials Research Report on DLBCL, Diffused Large B Cell Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
P-CD19CD20-ALLO1, Rimiducid - Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma
Phase 1Active not recruitingPoseida Therapeutics, Inc.1202024-04-162026-05-07

Narrower conditions

Dendritic Cell Sarcoma, Interdigitating (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytosis (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

Poseida Therapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Simon Heidegger, MD (1)